Dr. Randhir Sud, Chairman, Gastrosciences, Digestive And Hepatobiliary

About Dr. Randhir Sud

Dr. Randhir Sud is an experienced Gastroenterologist and Hepatologist at Medanta The Medicity, with expertise in advanced liver disease management, inflammatory bowel disease, and therapeutic endoscopy. With over 12 years of clinical practice, Dr. Sud has managed complex hepatology cases including hepatitis B and C, liver cirrhosis, and patients being evaluated for liver transplantation. Training at India’s leading gastroenterology institutions has been complemented by international exposure to advanced endoscopic techniques. Kazakhstan has the highest prevalence of Hepatitis B in Central Asia — a fact that makes Indian hepatology expertise particularly relevant for CIS patients. Patients from Kazakhstan, Uzbekistan, and Russia regularly consult Dr. Sud for liver disease management, bariatric consultations, and advanced endoscopic procedures at costs 60% lower than comparable treatment in Turkey or Germany. MediKaya Healthcare provides complete Russian-language coordination.

Experience Overview

Dr. Randhir Sud has over 35 years of experience in Gastroenterology and Hepatobiliary Sciences. As the Chairman of Gastrosciences at Medanta – The Medicity, Gurugram, he has extensive expertise in GI Endoscopy, GI Oncology, Hepatic Diseases, and advanced gastrointestinal procedures. Dr. Sud has performed numerous complex endoscopic interventions, including therapeutic procedures for gastrointestinal cancers and liver diseases. His vast experience in both diagnostic and therapeutic endoscopy makes him a renowned specialist in the management of digestive and liver disorders, contributing significantly to advancements in gastrosciences and patient care.

Conditions Treated

Dr. Randhir Sud specialises in the diagnosis and management of:

• Liver Cirrhosis Treatment
• Hepatitis B & C Management
• Non-Alcoholic Fatty Liver Disease (NAFLD)
• Inflammatory Bowel Disease (IBD — Crohn’s, Colitis)
• Gallstone Disease
• Pancreatitis (Acute & Chronic)
• Colonoscopy & Advanced Endoscopy
• Bariatric Surgery (Gastric Bypass, Sleeve)
• Peptic Ulcer Disease
• Oesophageal Disorders & GERD

Why CIS Patients Choose Dr. Randhir Sud?

Patients from Kazakhstan, Uzbekistan, Russia and across the CIS region choose Dr. Randhir Sud at Medanta The Medicity because:

Kazakhstan has the highest prevalence of Hepatitis B in Central Asia, and liver cirrhosis rates are significantly above the global average. India’s hepatology centres — particularly ILBS Delhi, Medanta Liver Institute, and Fortis — offer advanced liver disease management unavailable locally. Treatment cost in India is 60% lower than in Turkey or Germany, with comparable outcomes. MediKaya coordinates Russian-language communication throughout.

Through MediKaya Healthcare, all international patients from CIS countries receive dedicated Russian-speaking coordination from the moment of first inquiry through to post-treatment follow-up. Dr. Sud’s team at Medanta The Medicity is experienced in treating international patients and ensures all communication, medical reports, and treatment plans are clearly explained in Russian.

Professional Memberships

Dr. Randhir Sud holds the following professional memberships:

• Member of the American Society for Gastrointestinal Endoscopy (ASGE)
• Member of the Indian Society of Gastroenterology (ISG)
• Member of the Society of Gastrointestinal Endoscopy of India (SGEI)

These memberships reflect Dr. Sud’s dedication to staying current with the latest advancements in gastroenterology and endoscopy, ensuring that his patients receive the most up-to-date treatments based on cutting-edge research and best practices.

Languages Spoken

Dr. Randhir Sud is proficient in the following languages:

• English
• Hindi

His fluency in these languages enables effective communication with a diverse patient population, ensuring clear and personalized care for his patients.

Frequently Asked Questions

Q: Can liver cirrhosis be treated and reversed in India?

A: Liver cirrhosis cannot be fully reversed, but its progression can be halted and managed effectively. India’s hepatologists specialise in antiviral therapies, portal hypertension management, and ascites control. Patients with advanced cirrhosis are evaluated for liver transplantation.

Q: What is the cost of Hepatitis C treatment in India?

A: Hepatitis C treatment in India costs $500–$1,500 for a full 12-week course using generic direct-acting antivirals (sofosbuvir-based regimens) approved by the Indian government. The same treatment in Kazakhstan costs $3,000–$8,000 at private clinics.

Q: Is bariatric surgery (weight loss surgery) available in India for international patients?

A: Yes. Laparoscopic gastric sleeve, gastric bypass (Roux-en-Y), and mini-gastric bypass are routinely performed. Cost: $4,000–$6,000 in India vs $12,000–$20,000 in Turkey or Europe. Hospital stay: 3–5 days.

Q: How do I know if I need a liver transplant?

A: Liver transplant is considered when MELD score exceeds 15 or when complications (bleeding varices, hepatic encephalopathy, SBP) are uncontrolled. Send your recent LFT, AFP, ultrasound, and fibroscan reports to MediKaya for a free transplant eligibility assessment.

Q: Can colonoscopy be done in India as a tourist?

A: Yes. Colonoscopy with biopsy if needed can be arranged within 24–48 hours of arrival. Many CIS patients combine a diagnostic colonoscopy with a health check package during a 5–7 day medical visit.